SCHEMBL760020

SCHEMBL760020

CCCC1CC1N

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13063337 1.00 — —
SCHEMBL14616020 1.00 — —
SCHEMBL18748368 0.97 CA1 (0.37) —
Acetic Acid SCHEMBL27809336 0.83 SLC6A12 (0.50) —
SCHEMBL11881699 0.82 — —
SCHEMBL21746023 0.80 — —
SCHEMBL2877408 0.80 — —
SCHEMBL462039 0.80 — —
SCHEMBL462038 0.80 — —
SCHEMBL28782697 0.80 NOS1 (0.32) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170169921-A1 ENHANCED MAGNETIC LOSS Y- PHASE HEXAGONAL FERRITE FOR MAGNETODIELECTRIC ANTENNA APPLICATIONS SKYWORKS SOLUTIONS, INC. 2017-06-15 — — US disclosed
US-8285919-B2 SSD with improved bad block management INITIO CORPORATION (US) 2012-10-09 — — US disclosed
EP-1910364-B1 SPIROPIPERIDINE BETA-SECRETASE INHIBITORS FOR THE TREATMENT OF ALZHEIMER'S DISEASE MERCK SHARP & DOHME (US) 2012-03-21 — — EP disclosed
CN-101076519-B Amide compound and thrombopoietin receptor activator NISSAN CHEMICAL IND LTD 2011-07-20 — — CN disclosed
CN-101801925-A antiviral compounds GILEAD SCIENCES INC 2010-08-11 — — CN disclosed
US-20100122022-A1 SSD WITH IMPROVED BAD BLOCK MANAGMENT INITIO CORPORATION (US) 2010-05-13 — — US disclosed
CN-101076519-A Amide compound and thrombopoietin receptor activator NISSAN CHEMICAL IND LTD (JP) 2007-11-21 — — CN disclosed
Send feedback